Senate Hearing on Pandemic Discusses Reshoring Pharma, PPE
A Senate hearing today looked back at our early response to the pandemic. A year later, what went right, what went wrong, and how to re-shore pharma now.
A Senate hearing today looked back at our early response to the pandemic. A year later, what went right, what went wrong, and how to re-shore pharma now.
Lawyers from Wiley are telling their clients to prepare for ongoing supply disruptions due to Biden’s China policies.
A Hudson Institute webinar suggests that the U.S. is in a better position to take on China than Europe.
Biden’s new tax proposal benefits renewable energy. But where tax credits are concerned, can individuals and companies that get those tax credits then use the capital to import green tech from China? What’s stopping them?
The Department of Commerce heard a panel of industry leaders on Thursday discussing the shortage in semiconductors, and asks why we can’t make this stuff at home.
We are heading for a trillion-dollar deficit this year in manufactured goods unless some serious import substitution takes place.
It’s time for Elizabeth Warren to re-introduce her pharmaceutical supply chain legislation.
A new bill in the Senate seeks to prevent China solar imports, especially for publicly funded solar installations.
Biden releases 10-year $2 trillion infrastructure spending plan. Here’s what’s inside.
China’s duty-free import scheme may look like a desperation move, but it will facilitate massive purchasing and inventory build-out for China semiconductor companies looking to ramp up fast.